A carregar...
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
BACKGROUND: Approximately 15–20% of ulcerative colitis patients and 20–40% of those with Crohn’s disease experience extraintestinal manifestations (EIMs) of their inflammatory bowel disease (IBD). Clinicians who treat IBD must manage EIMs affecting multiple organs that variably correlate with intest...
Na minha lista:
| Publicado no: | Dig Dis Sci |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5854745/ https://ncbi.nlm.nih.gov/pubmed/29484571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-018-4971-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|